BIOLABEX Opens R&D Laboratory in BioPark Mauritius

First GMP-compliant CDMO in the Indian Ocean

 

Mauritius, 22 February 2017 – BIOLABEX, a Mauritius-based R&D Laboratory, today announces the launch of its development and manufacturing activities in BioPark Mauritius. Recently accredited as the first GMP-compliant CDMO (Contract Development and Manufacturing Organisation) in the Indian Ocean, BIOLABEX provides cosmetics,pharmaceutical, and nutraceutical companies with a full spectrum of R&D and consulting services - in early development, formulation, manufacturing, concept marketing, regulatory affairs, and compliance audits.

 

“Mauritius is widely regarded as one of the world’s biodiversity hotspots and we saw great potential in locating our first laboratory here,” said Marc LABICHE, CEO of BIOLABEX. “We also have an office in Paris, and this dual presence allows BIOLABEX, and its clients, to draw benefits from the best of both worlds - close proximity to a rich source of active ingredients, and to leading players in the pharmaceutical and cosmetics industries. These factors place BIOLABEX in a prime position to serve as a global hub.”

 

Occupying 500 sqm of laboratory space, the BIOLABEX is fully equipped with state-of-the-art technology managed by an international team of experts from diverse backgrounds. Through leveraging on the combined expertise and technology, BIOLABEX aims to develop the best solutions to suit the business needs of clients, in compliance with international standards.

 

With these new activities, BIOLABEX complements the existing R&D capabilities offered in BioPark Mauritius, the first biotechnological hub in the Indian Ocean.  The other key players include CIDP, an internationally recognised CRO (Contract Research Organisation), and QUANTILAB, a multi-disciplinary analytical laboratory specialised in microbiology, organic, and inorganic chemistry. Together, the three partners offer cosmetics, pharmaceutical, and nutraceutical clients a full R&D package, from the sourcing of active ingredients to product commercialisation.

 

To date, BIOLABEX has collaborated with a number of key clients, including one of dermatology sector’s largest players.

 

Marc concluded, “For now, our focus is on the cosmetics, pharmaceutical, and nutraceutical market in Europe and US, before looking towards promising markets such as Africa and Asia. Our future plans include expansion of our clientele to other industries, such as medical devices, food supplements, and agriculture.”

 

About BIOLABEX

 

Strategically located in Mauritius and Paris, BIOLABEX is the first GMP-compliant Contract Development and Manufacturing Organisation (CDMO) in the Indian Ocean. As a centre of expertise, BIOLABEX provides companies with a wide spectrum of R&D and consulting services, covering the areas of early development, formulation, manufacturing, concept marketing, regulatory affairs, and compliance audits.

 

With its headquarters in Mauritius, BIOLABEX is a key player in the full suite of services proposed by the BioPark Mauritius, which brings together the most successful biotech companies. Located in the heart of the Indian Ocean and close to Madagascar, the laboratory is located near a source active ingredients from a rich biodiversity for R&D activities, while its Paris office allows close access to its main clients - leading players in the pharmaceutical and cosmetics industries in Europe and US. This dual presence enables BIOLABEX to serve as a hub in a globalised world.

 

At present, BIOLABEX works with the leaders of the cosmetics, pharmaceutical, and nutraceutical industries to boost and support a variety of development projects, in compliance with international standards.

 

For more information, visit .

 

Contact

 

BIOLABEX

CIDP Mauritius BioPark Mauritius

Socota Phoenicia, Sayed Hossen Road

73408 Phoenix Mauritius

MAURITIUS

Email: info@biolabex.com

Tel: +230 4276140 

 

52, rue des Meuniers

92220 Bagneux, France

PARIS

Email: info@biolabex.com

Tel: +33(0)952846228 

 

Editorial Contact

Ms Alina TEE

Tel: +65 6220 4787

Email: alina@redbugpr.com